0001368148-20-000030.txt : 20200401 0001368148-20-000030.hdr.sgml : 20200401 20200401180156 ACCESSION NUMBER: 0001368148-20-000030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200330 FILED AS OF DATE: 20200401 DATE AS OF CHANGE: 20200401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Campbell Laura K CENTRAL INDEX KEY: 0001402605 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33876 FILM NUMBER: 20766729 MAIL ADDRESS: STREET 1: 3201 CARNEGIE AVENUE CITY: CLEVELAND STATE: OH ZIP: 44115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ATHERSYS, INC / NEW CENTRAL INDEX KEY: 0001368148 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 204864095 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3201 CARNEGIE AVENUE CITY: CLEVELAND STATE: OH ZIP: 44115-2634 BUSINESS PHONE: 216-431-9900 MAIL ADDRESS: STREET 1: 3201 CARNEGIE AVENUE CITY: CLEVELAND STATE: OH ZIP: 44115-2634 FORMER COMPANY: FORMER CONFORMED NAME: BTHC VI Inc DATE OF NAME CHANGE: 20060629 4 1 wf-form4_158577849369298.xml FORM 4 X0306 4 2020-03-30 0 0001368148 ATHERSYS, INC / NEW ATHX 0001402605 Campbell Laura K 3201 CARNEGIE AVENUE CLEVELAND OH 44115-2634 0 1 0 0 Senior Vice Pres Finance Common Stock 2020-03-30 4 S 0 44929 2.4001 D 561005 D Common Stock 2020-03-31 4 S 0 51483 2.9011 D 509522 D Common Stock 2020-04-01 4 S 0 47339 3.4035 D 462183 D Common Stock 2020-04-01 4 S 0 47474 3.8111 D 414709 D Common Stock 2020-04-01 4 S 0 43081 4.2559 D 371628 D Shares sold pursuant to a predefined Rule 10b5-1 trading plan that commenced in July 2018. A predefined number of shares may be sold from time-to-time based on predefined price increases over a two-year period. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $2.405, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.90 to $2.909, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.40 to $3.44, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.80 to $3.84, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.25 to $4.285, inclusive. Securities beneficially owned are comprised of (1) 250,072 shares of common stock owned and (2) unvested restricted stock units aggregating 121,556 related to annual awards, which vest quarterly over a three or four-year period from date of grant. /s/ Laura K. Campbell 2020-04-01